Medtronic says "Me too" on Painful Diabetic Neuropathy...Opioid Sparing Tech Flourishes

[drusso]

Medtronic announces FDA approval of spinal cord stimulation therapy for treating chronic pain resulting from diabetic peripheral neuropathy

/PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has received U.S. Food and Drug Administration approval...

www.prnewswire.com

"Medtronic estimates that up to 800,000 US patients suffer from moderate to severe DPN symptoms that are not resolved through conventional medical management approaches, like drugs. The company views these patients as potential candidates for SCS, representing an approximate $1.8 billion annual market opportunity. Today, Medtronic estimates that the US market revenue for SCS treatment of chronic pain associated with DPN, sometimes also referred to as Painful Diabetic Neuropathy (PDN), is approximately $70 million, and the company expects market revenue to grow to $300 million by fiscal year 2026."

---

Members don't see this ad.

 

[Orin]

Their data was technically first...

 

[RoloTomassi]

Nevro Responds to Competitor's Announcement of FDA Approval for Painful Diabetic Neuropathy

 

[drusso]

Nevro Responds to Competitor's Announcement of FDA Approval for Painful Diabetic Neuropathy

 

[Baron Samedi]

A nonrechargeable option for DPN patients will be huge.

 

[gaspasser127]

$NVRO is at a 2.5 year low.. around $69 a share at market close.

The real question is what’s their path to viability? Get bought out by another company? Bankruptcy like Nuvectra? Should they take on more debt and by another company and diversify?

 

[drusso]

$NVRO is at a 2.5 year low.. around $69 a share at market close.

The real question is what’s their path to viability? Get bought out by another company? Bankruptcy like Nuvectra? Should they take on more debt and by another company and diversify?

If I were Stryker, I'd buy them.

 

[gaspasser127]

If I were Stryker, I'd buy them.

Might be a good buy for Abbott

Or after that lawsuit they had recently, Boston Scientific can buy them and walk into the Nevro HQ like Ari Gold

 

[BobBarker]

Market cap still very high.

 

[Baron Samedi]

The end is nigh...

I've noticed the Nevro steak dinners have slowed down the last few months and the reps have stopped wearing designer suits. They're going the way of Nuvectra.

 

[gaspasser127]

Nevro KOLs jumping ship and joining other companies - Abbott, PainTeq, Minuteman, etc.

Nevro held no national fellows training lab this year… while every other company did. I think that’s telling.